Rekvina Labs Ltd.
| BSE: 526075 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE092O01028 |
| BSE 00:00 | 30 Mar | Rekvina Labs Ltd is not traded on BSE in the last 30 days |
| NSE 05:30 | 01 Jan | Rekvina Labs Ltd Not listed in NSE |
| OPEN | 3.97 |
| PREVIOUS CLOSE | 3.97 |
| VOLUME | 267 |
| 52-Week high | 4.17 |
| 52-Week low | 3.97 |
| P/E | |
| Mkt Cap.(Rs cr) | 2 |
| Buy Price | 3.97 |
| Buy Qty | 233.00 |
| Sell Price | 3.97 |
| Sell Qty | 4999.00 |
About Rekvina Labs Ltd.
Rekvina Labs Ltd
Rekvina Labs Ltd was incorporated on 1st November 1988. The Company is registered in England and Wales as a Public Limited Company. The company is mainly engaged in manufacturing and marketing of pharmaceutical products. It presently operates into one business segment i.e. copper extrusion.During FY2015 the company sub divided its existing equity shares in such a manner that every shareholder hold...> More
Rekvina Labs Ltd - Key Fundamentals
| Parameter | Values | ||
| Market Cap | ( cr) |
2 | |
| EPS - TTM | () |
[*S] | - |
| P/E Ratio | (X) | [*S] | - |
| Face Value | () |
5 | |
| Latest Dividend | (%) | - | |
| Latest Dividend Date | - | ||
| Dividend Yield | (%) | 0.00 | |
| Book Value / Share | () |
[*S] | 0.23 |
| P/B Ratio | () |
[*S] | 17.26 |
Announcement
-
Compliances - Reg. 40(9) & (10) - PCS Certificate For Transfer / Transmission / Transposition
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
-
Compliances - Compliance Certificate For The Period Ended March 2021
-
Statement Of Investor Complaints For The Quarter Ended March 2021
Rekvina Labs Ltd - Financial Results
Particulars ( cr) |
Dec 2020 | Dec 2019 | % Chg |
| Net Sales | - | ||
| Other Income | 0.15 | - | |
| Total Income | 0.15 | - | |
| Total Expenses | 0.03 | 0.08 | -62.5 |
| Operating Profit | -0.03 | 0.07 | -142.86 |
| Net Profit | -0.03 | 0.07 | -142.86 |
| Equity Capital | 3.01 | 3.01 | - |
Rekvina Labs Ltd - Peer Group
| Company | Price() |
Chg (%) | Mkt Cap ( CR) |
| Hind.Bio Science | 4.09 | -4.88 | 4.19 |
| Unjha Formul. | 8.57 | 4.90 | 3.84 |
| Welcure Drugs | 2.34 | 1.74 | 3.16 |
| Kabra Drugs | 3.83 | -3.53 | 1.68 |
Rekvina Labs Ltd - SHAREHOLDING PATTERN
|
|
|
Promoters
Banks/FIs
FIIs
Insurance
Mutual Funds
Indian Public
Custodians
OtherRekvina Labs Ltd - RETURNS
| Period | BSE | NSE | Sensex | NIFTY |
| 1 Week | NA | NA | -0.96% | -0.98% |
| 1 Month | NA | NA | 0.39% | 1.19% |
| 3 Month | NA | NA | -5.46% | -3.20% |
| 6 Month | NA | NA | 11.67% | 14.85% |
| 1 Year | NA | NA | 56.58% | 60.54% |
| 3 Year | NA | NA | 37.06% | 35.82% |
Rekvina Labs Ltd - STOCK STRENGTH
| Today's Low/High | 3.97 |
|
3.97 |
| Week Low/High | 0.00 |
|
3.97 |
| Month Low/High | 0.00 |
|
3.97 |
| YEAR Low/High | 3.97 |
|
4.00 |
| All TIME Low/High | 0.50 |
|
78.00 |
Quick Links for Rekvina Labs:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
